These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12615037)

  • 1. Influenza-virus-induced signaling cascades: targets for antiviral therapy?
    Ludwig S; Planz O; Pleschka S; Wolff T
    Trends Mol Med; 2003 Feb; 9(2):46-52. PubMed ID: 12615037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Two Sides of the Same Coin-Influenza Virus and Intracellular Signal Transduction.
    Ludwig S; Hrincius ER; Boergeling Y
    Cold Spring Harb Perspect Med; 2021 Jan; 11(1):. PubMed ID: 31871235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of cellular signaling pathway inhibitors as new antivirals against influenza.
    Planz O
    Antiviral Res; 2013 Jun; 98(3):457-68. PubMed ID: 23603495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of influenza virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo.
    Pinto R; Herold S; Cakarova L; Hoegner K; Lohmeyer J; Planz O; Pleschka S
    Antiviral Res; 2011 Oct; 92(1):45-56. PubMed ID: 21641936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herbal Medicines with Antiviral Activity Against the Influenza Virus, a Systematic Review.
    Lee JY; Abundo MEC; Lee CW
    Am J Chin Med; 2018; 46(8):1663-1700. PubMed ID: 30612461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influenza viruses and intracellular signalling pathways].
    Planz O
    Berl Munch Tierarztl Wochenschr; 2006; 119(3-4):101-11. PubMed ID: 16573200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy.
    Ludwig S
    J Antimicrob Chemother; 2009 Jul; 64(1):1-4. PubMed ID: 19420020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling.
    Varghese FS; Thaa B; Amrun SN; Simarmata D; Rausalu K; Nyman TA; Merits A; McInerney GM; Ng LFP; Ahola T
    J Virol; 2016 Nov; 90(21):9743-9757. PubMed ID: 27535052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive Oxygen Species-Regulating Polymersome as an Antiviral Agent against Influenza Virus.
    Kim HO; Yeom M; Kim J; Kukreja A; Na W; Choi J; Kang A; Yun D; Lim JW; Song D; Haam S
    Small; 2017 Aug; 13(32):. PubMed ID: 28692767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses.
    Nacken W; Ehrhardt C; Ludwig S
    Biol Chem; 2012 May; 393(6):525-34. PubMed ID: 22628315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host cellular signaling induced by influenza virus.
    Dai X; Zhang L; Hong T
    Sci China Life Sci; 2011 Jan; 54(1):68-74. PubMed ID: 21253874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems biology of influenza: understanding multidimensional interactions for personalized prevention and treatment.
    Yan Q
    Methods Mol Biol; 2010; 662():285-302. PubMed ID: 20824477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivo.
    Haasbach E; Müller C; Ehrhardt C; Schreiber A; Pleschka S; Ludwig S; Planz O
    Antiviral Res; 2017 Jun; 142():178-184. PubMed ID: 28377100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza virus resistance to antiviral therapy.
    van der Vries E; Schutten M; Fraaij P; Boucher C; Osterhaus A
    Adv Pharmacol; 2013; 67():217-46. PubMed ID: 23886002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of NF-kappa B in virus-infected macrophages is dependent on mitochondrial oxidative stress and intracellular calcium: downstream involvement of the kinases TGF-beta-activated kinase 1, mitogen-activated kinase/extracellular signal-regulated kinase kinase 1, and I kappa B kinase.
    Mogensen TH; Melchjorsen J; Höllsberg P; Paludan SR
    J Immunol; 2003 Jun; 170(12):6224-33. PubMed ID: 12794154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections.
    Ludwig S
    Biol Chem; 2011 Oct; 392(10):837-47. PubMed ID: 21823902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical inhibition of RNA viruses reveals REDD1 as a host defense factor.
    Mata MA; Satterly N; Versteeg GA; Frantz D; Wei S; Williams N; Schmolke M; Peña-Llopis S; Brugarolas J; Forst CV; White MA; García-Sastre A; Roth MG; Fontoura BM
    Nat Chem Biol; 2011 Sep; 7(10):712-9. PubMed ID: 21909097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza viruses and the NF-kappaB signaling pathway - towards a novel concept of antiviral therapy.
    Ludwig S; Planz O
    Biol Chem; 2008 Oct; 389(10):1307-12. PubMed ID: 18713017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases.
    Nijhuis M; van Maarseveen NM; Boucher CA
    Handb Exp Pharmacol; 2009; (189):299-320. PubMed ID: 19048205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses.
    Shih SR; Horng JT; Poon LL; Chen TC; Yeh JY; Hsieh HP; Tseng SN; Chiang C; Li WL; Chao YS; Hsu JT
    J Antimicrob Chemother; 2010 Jan; 65(1):63-71. PubMed ID: 19892833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.